Our Exciting Journey to ACT-451840
We describe our work resulting in the selection of ACT-451840 ( 38 ) as a novel antimalarial drug with a novel mode of action. The compound was broadly characterized in vitro as well as in vivo in rat PK experiments as well as two different mouse malaria models. In the P. berghei infected mouse mode...
Enregistré dans:
Auteurs principaux: | Christoph Boss, Sergio Wittlin |
---|---|
Format: | article |
Langue: | DE EN FR |
Publié: |
Swiss Chemical Society
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/93b7c702dfa74ab3aef04287a807090c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fostering Research Synergies between Chemists in Swiss Academia and at Novartis
par: Arndt Meyer, et autres
Publié: (2021) -
Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
par: Annarita Del Gatto, et autres
Publié: (2021) -
Editorial: Protein–Protein Interactions: Drug Discovery for the Future
par: Simona Rapposelli, et autres
Publié: (2021) -
Click Chemistry in Natural Product Modification
par: Xiang Zhang, et autres
Publié: (2021) -
Challenges, Advances and Opportunities in Exploring Natural Products to Control Arboviral Disease Vectors
par: Daniel P. Demarque, et autres
Publié: (2021)